Condition: Gastric Cancer · Atrophic Gastritis · Gastric Dysplasia · Sponsor: University of Latvia
The study is aimed to determine the potential of volatile marker testing for gastric cancer screening. The study will be addressing the role of confounding factors, including lifestyle factors, diet, smoking as well as addressing the potential role of microbiota in the composition of exhaled volatile markers.
This description comes directly from the study's public registry record.
Marcis Leja, MD, PhD · +37129497500 · marcis.leja@lu.lv
Daiga Santare, MD, PhD · +37129221107 · daiga.santare@lu.lv
Always discuss trial participation with your own doctor first.
| A.C.Camargo Cancer Center | São Paulo, Brazil | Recruiting |
| Pontificia Universidad Catolica de Chile | Santiago, Chile | Not Yet Recruiting |
| Centro Javeriano de Oncología, San Ignacio University Hospital | Bogotá, Colombia | Not Yet Recruiting |
| Institute of Clinical and Preventive Medicine, University of Latvia | Riga, Latvia | Recruiting |
| National Cancer Institute of Ukraine | Kiev, Ukraine | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04022109